Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
about
Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
description
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Two-year outcome of treat-and- ...... horoidal vasculopathy patients
@en
Two-year outcome of treat-and- ...... horoidal vasculopathy patients
@nl
type
label
Two-year outcome of treat-and- ...... horoidal vasculopathy patients
@en
Two-year outcome of treat-and- ...... horoidal vasculopathy patients
@nl
prefLabel
Two-year outcome of treat-and- ...... horoidal vasculopathy patients
@en
Two-year outcome of treat-and- ...... horoidal vasculopathy patients
@nl
P2093
P2860
P356
P1476
Two-year outcome of treat-and- ...... horoidal vasculopathy patients
@en
P2093
Asako Ogawa
Aya Matsuda
Hiroko Inui
Hiroshi Murata
Keiko Azuma
Kimiko Shimizu
Motoshi Yamamoto
Ryo Asaoka
P2860
P304
P356
10.2147/OPTH.S172115
P407
P577
2018-01-01T00:00:00Z